封面
市場調查報告書
商品編碼
1513584

血管影像市場規模- 按模式(電腦斷層掃描、MRI、超音波、核子醫學、X 光)、應用(診斷、治療)、程序(冠狀動脈造影、周邊血管造影)、最終用途和全球預測,2024 年- 2032 年

Vascular Imaging Market Size - By Modality (Computed Tomography, MRI, Ultrasound, Nuclear Medicine, X-Ray), Application (Diagnostic, Therapeutic), Procedure (Coronary Angiography, Peripheral Angiography), End-use & Global Forecast, 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 210 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於新興經濟體為支持開發和採用診斷血管疾病的先進影像技術而增加的醫療保健資金,全球血管影像市場規模從 2024 年到 2032 年將以 5.9% 的複合年成長率擴大。研究人員和醫療保健提供者正在探索新技術並增強現有模式,以提高診斷準確性和患者治療結果。

正在進行的投資還有助於將先進技術融入日常醫療實踐中,以加強醫療基礎設施並提高血管健康先進診斷工具的可近性。例如,2023 年 10 月,雅培推出了由 Ultreon 1.0 軟體提供支援的新型血管影像平台,以增強醫生可視化血流和識別冠狀動脈阻塞的能力。

市場分為模式、應用、程序、最終用途和區域。

就模式而言,由於提供血流和血管健康的非侵入性見解的進步,超音波血管成像行業預計到 2032 年將經歷顯著的成長。超音波被醫療保健專業人員廣泛用於診斷深部靜脈血栓和動脈狹窄等疾病。超音波技術的不斷發展進一步增強了其提高血管成像解析度和準確性的能力。

按最終用途分類,診斷成像中心領域的血管成像市場預計將從 2024 年到 2032 年成長,因為這些設置採用超音波和 MRI 等各種技術來評估血流並識別血管異常。這些中心正在增強其成像技術,以提高診斷準確性和患者護理。他們還透過整合先進的成像模式來擴展其能力,以實現更精確的血管健康評估。

從地區來看,在政府大力支持和持續醫療改革的帶動下,亞太地區血管成像行業規模預計將在 2024 年至 2032 年間出現強勁成長。多項措施正在支持在醫療機構中採用先進的影像技術。在基礎設施和培訓方面進行了大量投資,以提高血管成像服務的可及性和品質。不斷努力將先進成像模式融入常規醫療實踐,以確保整個地區診斷能力的提高和患者治療效果的改善,這將有利於市場的成長。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 癌症和心臟病的盛行率上升
      • 技術進步與產品創新
      • 對預防保健和疾病篩檢計劃的認知不斷增強
      • 有利的政府舉措
    • 產業陷阱與挑戰
      • 增加翻新產品的使用
      • 與產品相關的高成本
  • 成長潛力分析
  • 監管環境
  • 技術景觀
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司市佔率分析
  • 競爭定位矩陣
  • 公司矩陣分析
  • 戰略展望矩陣

第 5 章:市場估計與預測:按模式,2021 - 2032 年

  • 主要趨勢
  • CT檢查
  • 核磁共振成像
  • 超音波
  • 核子醫學
  • X光

第 6 章:市場估計與預測:按應用分類,2021 - 2032

  • 主要趨勢
  • 診斷
  • 治療性

第 7 章:市場估計與預測:按程序,2021 - 2032

  • 主要趨勢
  • 冠狀動脈造影
  • 周邊血管攝影
  • 神經血管攝影
  • 血管超音波
  • 顯微血管攝影
  • 腦血管攝影
  • 其他手續

第 8 章:市場估計與預測:按最終用途,2021 - 2032 年

  • 主要趨勢
  • 醫院
  • 診斷影像中心
  • 其他最終用戶

第 9 章:市場估計與預測:按地區分類,2021 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 10 章:公司簡介

  • Abbott Laboratories
  • Carestream Health
  • GE HealthCare Technologies Inc.
  • Hitachi, Ltd.
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • SAMSUNG ELECTRONICS Co., Ltd
  • Shimadzu Corporation
  • Siemens Healthineer AG
  • Terumo Corporation
簡介目錄
Product Code: 9106

Global Vascular Imaging Market size will expand at 5.9% CAGR from 2024 to 2032 due to increasing healthcare funding in emerging economies for supporting the development and adoption of advanced imaging technologies for diagnosing vascular conditions. Researchers and healthcare providers are exploring new techniques and enhancing existing modalities to improve diagnostic accuracy and patient outcomes.

The ongoing investments are also helping in integrating advanced technologies into routine medical practices to strengthen healthcare infrastructures and enhance accessibility to advanced diagnostic tools for vascular health. For instance, in October 2023, Abbott introduced its new vascular imaging platform powered by Ultreon 1.0 Software for enhancing the ability of physicians to visualize blood flow and identify coronary artery blockages.

The market is segregated into modality, application, procedure, end-use, and region.

In terms of modality, the ultrasound vascular imaging industry is set to experience significant growth rate through 2032 due to advancements for providing non-invasive insights into blood flow and vascular health. Ultrasound is widely used by healthcare professionals for diagnosing conditions, such as deep vein thrombosis and arterial stenosis. The increasing developments in ultrasound technology are further enhancing its capabilities for improving resolution and accuracy in vascular imaging.

By end-use, the vascular imaging market from the diagnostic imaging centres segment is projected to rise from 2024 to 2032, as these settings employ various techniques, such as ultrasound and MRI to assess blood flow and identify vascular abnormalities. These centers are enhancing their imaging technologies to improve diagnostic accuracy and patient care. They are also expanding their capabilities by integrating advanced imaging modalities for enabling more precise assessments of vascular health.

Regionally, the Asia Pacific vascular imaging industry size is projected to depict robust growth between 2024 and 2032, led by the surging government support and ongoing healthcare reforms. Several initiatives are supporting the adoption of advanced imaging technologies across healthcare facilities. There have been significant investments in infrastructure and training to enhance the accessibility and quality of vascular imaging services. Rising efforts for integrating advanced imaging modalities into routine medical practices for ensuring improved diagnostic capabilities and better patient outcomes across the region will favor the market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of cancer and cardiac diseases
      • 3.2.1.2 Technological advances and innovation in products
      • 3.2.1.3 Growing awareness towards preventive healthcare and disease screening programs
      • 3.2.1.4 Favorable government initiatives
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Increasing use of refurbished products
      • 3.2.2.2 High cost associated with the products
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Company matrix analysis
  • 4.5 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Modality, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Computed tomography
  • 5.3 MRI
  • 5.4 Ultrasound
  • 5.5 Nuclear medicine
  • 5.6 X-Ray

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Diagnostic
  • 6.3 Therapeutic

Chapter 7 Market Estimates and Forecast, By Procedure, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Coronary angiography
  • 7.3 Peripheral angiography
  • 7.4 Neurovascular angiography
  • 7.5 Vascular ultrasound
  • 7.6 Microangiography
  • 7.7 Cerebral angiography
  • 7.8 Other procedures

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Diagnostic imaging centers
  • 8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Abbott Laboratories
  • 10.2 Carestream Health
  • 10.3 GE HealthCare Technologies Inc.
  • 10.4 Hitachi, Ltd.
  • 10.5 Hologic, Inc.
  • 10.6 Koninklijke Philips N.V.
  • 10.7 SAMSUNG ELECTRONICS Co., Ltd
  • 10.8 Shimadzu Corporation
  • 10.9 Siemens Healthineer AG
  • 10.10 Terumo Corporation